Novel Developments in Stem Cell Mobilization: Focus on Cxcr4

This book reports on CXCR4 antagonists, an exciting new class of compounds that aid in use of stem cells for treatment of leukemia and other cancers. Includes coverage of plerixafor, now approved for stem cell mobilization of lymphoma and myeloma patients. Read More

This book reports on CXCR4 antagonists, an exciting new class of compounds that aid in use of stem cells for treatment of leukemia and other cancers. Includes coverage of plerixafor, now approved for stem cell mobilization of lymphoma and myeloma patients. Read Less

• All from $47.70
• New Books from $159.69
• eBook from $47.70

• • eBook Details

  	This is a digital edition of this title. Rent eBook (5 Options) 30 Day Rental: $47.70 (Expires Mar 21, 2025) 60 Day Rental: $63.60 (Expires Apr 20, 2025) 90 Day Rental: $79.50 (Expires May 20, 2025) 120 Day Rental: $95.40 (Expires Jun 19, 2025) 180 Day Rental: $103.35 (Expires Aug 18, 2025) Buy eBook Lifetime Access: $159.00 Title: Novel Developments in Stem Cell Mobilization by Stefan Fruehauf; Âw. Jens Zeller; Âgary Calandra Publisher: Springer Nature Print ISBN: 9781461419594, 146141959X eText ISBN: 9781461419600 Edition: 2012 1st edition Format: EPUB eBook	$47.70 Rent eBook This is a digital eBook Nothing will be shipped to you Works with web browsers and the VitalSource app on all Windows, Mac, Chromebook, Kindle Fire, iOS, and Android devices Most eBooks are returnable within 14 days of purchase Questions? See our eBook FAQ